Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study
about
Describing Point of Entry into Care and Being Lost to Program in a Cohort of HIV Positive Pregnant Women in a Large Urban Centre in UgandaAwareness and perceived fairness of Option B+ in Malawi: A population-level perspectiveExploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: A qualitative study.Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi.Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic modelAct local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy.Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B+ in Southern Malawi.ART attrition and risk factors among Option B+ patients in Haiti: A retrospective cohort study.Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial.Scaling-up antiretroviral therapy in MalawiAdherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ ProgramShort-term effectiveness of a community health worker intervention for HIV-infected pregnant women in Tanzania to improve treatment adherence and retention in care: A cluster-randomized trial.HIV Linkage to Care and Retention in Care Rate Among MSM in Guangzhou, China.Factors associated with retention in Option B+ in Malawi: a case control study.'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience.Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating 'Option B+' in the South West Region.Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.The Impact of Couple HIV Testing and Counseling on Consistent Condom Use Among Pregnant Women and Their Male Partners: An Observational Study.Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B+ in Tanzania.Trends in maternal deaths in HIV-infected women, on a background of changing HIV management guidelines in South Africa: 1997 to 2015.Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the prevention of mother-to-child transmission continuum of care: systematic review.Viraemia before, during and after pregnancy in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal, South Africa, 2010-2015.Addressing Early Retention in Antenatal Care Among HIV-Positive Women Through a Simple Intervention in Kinshasa, DRC: The Elombe "Champion" Standard Operating Procedure.Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: A Systematic Review and Meta-Analysis of Studies in Africa.She knows that she will not come back: tracing patients and new thresholds of collective surveillance in PMTCT Option B.Maximizing adherence and retention for women living with HIV and their infants in Kenya (MOTIVATE! study): study protocol for a randomized controlled trial.A Text Messaging Intervention to Support Option B+ in Kenya: A Qualitative Study.Increased prevalence of pregnancy and comparative risk of program attrition among individuals starting HIV treatment in East Africa."We have heard it together": a qualitative analysis of couple HIV testing and counselling recruitment in Malawi's Option B+ programme.Men's hopes, fears and challenges in engagement in perinatal health and the prevention of mother-to-child transmission of HIV in rural Kenya.The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis.Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.Infant HIV-Free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-Based Cohort Study from Rural Zambia.
P2860
Q33567167-12334B81-5C67-4D35-8753-BABB22B1E913Q33787646-1E668918-C122-43B3-A030-50D5BFBBB465Q33821909-529A94AC-0C4C-4427-8685-B8B23EA1B5E9Q33892081-9C24A9A2-0990-4746-A68E-5C9C79EE1D7BQ33898494-D8EB9374-D40A-4097-9479-BF0A1C1B75BFQ36124634-BEBC477F-70A0-4BFA-BC5D-4C16F7642ADBQ36230357-95522437-9464-4686-890A-0FDC94C8F9FEQ36298463-008CB55A-AC14-40D2-95BA-673F2C60DEC5Q36313626-259A749A-8576-4CCE-A080-1EFB6A835FB0Q37298518-B44AE30D-5B1E-4E22-B930-F261CEDA7D6FQ37339299-4B69583D-1DFE-4A38-8E26-59D1D9AFA525Q38599763-8B55C4B1-ADE9-4E19-9524-6837DF95AB1DQ38604466-7BDAD038-A953-41F5-BA38-3B4EA258331CQ38814822-BE14D848-76C7-40C9-97CF-A7316A9AEF1FQ38849560-1EDDB2E4-2C01-4E1D-9CB0-82A7B69C1A83Q38851836-957D4F9E-1F7F-4962-AC24-08F861489EF4Q38852269-C6FD1BEA-7783-4947-B56B-0AF00C99C2C1Q38882759-E2C2AEC1-AE47-4B4C-BF42-ED16E39C3BF8Q38984892-87E48418-9526-464A-B36D-DE13646A298CQ39024622-3D7B1D6F-4C9B-4F9E-8908-F13A5D81AFC2Q39121804-A90CA47C-4B17-4959-9D6D-E195AE8C25DDQ40051566-3194AD49-DA98-4B91-ACC9-A77A23AAF334Q40105458-2470E50E-0D12-4EFF-BAF6-32B3D265913DQ40234677-D5ED5C16-66DF-48CC-81E3-DDD282A7A8E7Q40268361-AAC7A14F-B054-4AD9-B050-2DEBBF13CFB3Q42366166-CC935CA2-8D47-4DA9-8804-0C070A69F741Q46153362-4A1BB312-412E-424C-8300-BC11A59F7F38Q46173117-BBE180E9-E4C1-4215-A9A0-255B4EB411D3Q46187732-AF6CC2CE-1FBE-40E9-8A3B-CC14E4F19698Q46531314-7A8654F3-D970-40DC-9A84-FCD8D3EB6433Q47234166-47790CAB-34F6-43E7-907F-88477BDDF194Q47547057-C20FF6BC-E553-4162-A6AB-0C540268DF35Q47548199-8F485FEC-B88D-44AF-9371-1EF8B4A10746Q47799071-7BEDF98E-46E7-49BD-987F-F2F9B1C8180CQ48226503-8CD40D13-7BF5-499B-9F24-4640760C4C28Q49602225-AFEA7BC3-3E58-42F7-A4EE-474975F3CBDCQ49714376-45608CB6-480C-418E-A569-F4A367785533Q49924713-BEFB6CF8-EE35-4378-99DF-CBD2F81FDF55Q52619035-FC7DA2B2-2F85-4444-AD8F-E6D37DFDA53AQ52619175-B05D1AB2-86AE-4FC5-AD8F-9900D187C55C
P2860
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Retention in care during the f ...... an observational cohort study
@en
type
label
Retention in care during the f ...... an observational cohort study
@en
prefLabel
Retention in care during the f ...... an observational cohort study
@en
P2093
P2860
P50
P1433
P1476
Retention in care during the f ...... an observational cohort study
@en
P2093
Andreas Jahn
Frank Chimbwandira
Joep J van Oosterhout
Lyson Tenthani
Malango T Msukwa
Oliver J Gadabu
Olivia Keiser
P2860
P304
P356
10.1016/S2352-3018(16)00008-4
P577
2016-03-09T00:00:00Z